|

Topical treatment Clinical Trials

1 actively recruiting trial

Also known as: Veregen 10% ointment

Pipeline

Phase 3: 1

Top Sponsors

  • Aresus Pharma GmbH1

Indications

  • Actinic Keratosis of Face and Scalp1
  • Cancer1

Other1 trial

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.